David C. Bupp
2010
In 2010, David C. Bupp earned a total compensation of $1.1M as President and Chief Executive Officer at Navidea Biopharmaceuticals, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $107,500 |
|---|---|
| Salary | $355,000 |
| Stock Awards | $584,700 |
| Other | $8,887 |
| Total | $1,056,087 |
Bupp received $584.7K in stock awards, accounting for 55% of the total pay in 2010.
Bupp also received $107.5K in non-equity incentive plan, $355K in salary and $8.9K in other compensation.
Rankings
In 2010, David C. Bupp's compensation ranked 5,088th out of 10,439 executives tracked by ExecPay. In other words, Bupp earned more than 51.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,088 out of 10,439 | 51st |
Division Manufacturing | 1,826 out of 3,838 | 52nd |
Major group Chemicals And Allied Products | 378 out of 926 | 59th |
Industry group Drugs | 225 out of 685 | 67th |
Industry In Vitro and In Vivo Diagnostic Substances | 11 out of 51 | 78th |
Source: SEC filing on July 10, 2012.
Bupp's colleagues
We found four more compensation records of executives who worked with David C. Bupp at Navidea Biopharmaceuticals in 2010.
2010
Mark Pykett
Navidea Biopharmaceuticals
Chief Executive Officer
2010
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2010
Brent Larson
Navidea Biopharmaceuticals
Chief Financial Officer
2010
Rodger Brown
Navidea Biopharmaceuticals